December 26, 2022
Shionogi said on December 23 that its China-based joint venture has entered into a license agreement with Shanghai Pharmaceutical for the importation and distribution of its oral COVID-19 treatment ensitrelvir, known as Xocova in Japan, in China. The deal was...read more